查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855383

兽用免疫诊断市场依产品类型、技术、动物种类、通路、应用及最终用户划分－2025-2032年全球预测

Veterinary Immunodiagnostics Market by Product Type, Technology, Animal Type, Distribution Channel, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，兽医免疫诊断市场规模将达到 27.4 亿美元，复合年增长率为 8.43%。

关键市场统计数据
基准年 2024 14.3亿美元
预计年份：2025年 15.4亿美元
预测年份 2032 27.4亿美元
复合年增长率 (%) 8.43%

全面检视技术创新、临床需求和营运现实如何融合，从而重新定义兽医免疫诊断学

兽医免疫诊断正处于曲折点，科学进步与不断变化的临床需求正在融合，重塑动物疾病的检测、管理和预防方式。过去十年，诊断平台已从客製化的实验室工作流程转型为更整合、自动化、快速反应的系统，能够在不同的医疗环境中做出及时的临床决策。因此，兽医、诊断实验室和研究机构越来越重视免疫诊断解决方案，不再仅仅将其视为试剂和仪器，而是将其视为更广泛的医疗保健生态系统的组成部分，该生态系统还包括数据分析、照护现场能力和供应链管理。

在这种瞬息万变的环境中，适应能力至关重要。相关人员必须在技术创新和营运可靠性这两大迫切需求之间取得平衡，同时也要应对不断变化的法律规范和采购惯例。因此，高阶主管需要清楚了解主流诊断方法、产品外形规格以及最终用户对产品应用的需求。此外，供应链的韧性、试剂品质以及与实验室资讯系统的互通性也正成为采购决策的关键因素。所有这些因素共同促使企业采取策略性方法，在科学严谨性、商业性可行性和服务交付模式之间取得平衡，以确保诊断解决方案能够满足日益复杂的兽医需求。

快速检测技术创新、工作流程自动化和不断发展的分销模式如何共同重塑兽医免疫诊断的未来

由于技术、临床和商业性趋势的融合，兽医免疫诊断领域正经历显着的变化。检测化学和检测平台的快速发展提高了分析灵敏度和通量，从而实现了更快、更准确的疾病检测。同时，自动化和整合仪器的兴起减少了人工时间和操作差异，使得诊断服务能够从专业实验室扩展到分散的临床机构。因此，产品设计越来越注重工作流程效率、可重复性和与数位化彙报系统的兼容性。

随着技术进步，临床需求也在不断增长，范围和复杂性日益增加。伴侣动物和牲畜的诊疗实践需要诊断技术来支持预防保健、疫情应对和食品安全保障。这种转变凸显了多重检测能力和快速週转的重要性，使兽医和生产者能够提供实证介入措施。此外，监管环境和品质保证要求也不断改进，促使製造商加强对验证、文件记录和上市后监测策略的投入，以证明产品的临床效用和可靠性。

商业模式也在不断演变。如今，分销管道融合了传统的线下关係和日益增长的线上采购管道，后者强调便利性和快速补货週期。随着企业寻求从整合的产品系列和服务中获取更大价值，诊断公司、製药公司和实验室网路之间的策略伙伴关係也不断加强。总而言之，这些变化凸显了整合策略的必要性，该策略应将产品创新与监管合规性、临床适用性和可扩展的分销管道相结合。

美国2025年关税对营运和采购的影响，以及产业参与者如何调整其采购和定价策略

2025年美国关税政策引入了一系列重新调整的贸易考量因素，将影响兽医免疫诊断供应链的采购筹资策略和成本结构。依赖跨境供应仪器、试剂和检测组件的製造商和经销商不得不重新评估其供应商合约、库存政策和供应商多元化策略，以确保服务的连续性。因此，采购团队正在加快供应商资质审核流程，并强调采用多源采购框架，以降低单点故障的风险。

此外，关税环境加剧了人们对本地产能和区域製造伙伴关係关係的关注。相关人员正积极探索近岸外包和双重采购方案，以减轻进口关税的影响，同时确保获得关键原料和特殊组件。此类重组通常需要前期投资于供应商开发和品质体系，以确保替代供应商符合诊断所需的验证标准。此外，经销商和临床终端用户也改进了库存管理实践，透过增加安全库存和与临床需求讯号相关的预测性补货，为应对突发的供应中断做好准备。

值得注意的是，主导调整也影响策略定价和合约签订方式。商务团队越来越多地协商包含关税减免和供应连续性条款的长期合同，而製造商则在探索附加价值服务组合，以证明价格调整的合理性。总而言之，这些因应措施反映了整个产业为在应对最新贸易措施带来的实际影响的同时，努力维持临床对关键免疫诊断工具的获取而做出的共同努力。

解读产品、技术、物种、分销、应用和最终用户细分，以帮助确定产品开发和商业化策略的优先顺序。

了解市场区隔的细微差别有助于明确产品开发和商业化工作的重点方向，从而满足多样化的临床和营运需求。从产品类型角度来看，市场可分为三大类：免疫检测套件、仪器、试剂。免疫检测套件包括化学冷光免疫检测套件、萤光免疫分析法套件(ELISA) 试剂套件、萤光免疫横向流动化验免疫分析套件和放射免疫测量套件，每种试剂盒都服务于不同的应用场景，从高通量实验室检测到照护现场筛检。仪器包括自动化免疫检测系统、化学冷光系统、发光仪和微孔盘读数仪，它们在通量、自动化程度和分析能力方面各有侧重。试剂包括抗原、抗体、缓衝液和溶液，这些都是检测性能的基础，需要严格的品管。

这些技术包括化学冷光免疫检测、流式细胞技术、萤光免疫分析、免疫组织化学、侧向流动免疫检测、放射免疫测量和西方印渍术。有些技术具有更高的灵敏度和定量能力，而有些技术则无需仪器即可快速部署，适用于现场使用。这些技术差异会影响验证路径、最终使用者培训和实验室整合等方面的决策。

动物类型的引入进一步细化了产品优先顺序。水生动物、伴侣动物和家畜各自呈现不同的流行病学特征和检测要求。伴侣动物诊断通常优先考虑犬猫应用，重点在于个人化护理和预防性筛检。相反，家畜诊断必须支持牛、羊、家禽和猪等畜牧业，这些畜群层面的监测、疫情的快速检测以及食品安全问题都影响着人们对产品的期望。

通路分为线下和线上，两者需要不同的服务模式。线下通路传统上专注于现场销售、技术支援和长期供货关係，而线上采购则加快了补货週期，并支援机构买家的标准化采购。应用领域涵盖自体免疫疾病诊断、癌症诊断、食品安全和品质检测、荷尔蒙和代谢紊乱诊断、感染疾病诊断、怀孕和不孕症检测以及毒素检测。这些应用案例驱动着检测设计、监管要求和临床验证终点。最终用户包括诊断实验室、製药和生物技术公司、研究机构以及兽医医院和诊所，每个用户都有各自的营运限制和采购标准，因此需要客製化的产品功能和服务。

综合来看，细分市场洞察凸显了产品系列、检验策略和通路方法的一致性的重要性，这反映了不同技术、动物类型和最终用途背景下的多样化需求。

美洲、欧洲、中东和非洲以及亚太地区的市场竞争和差异化需求将影响目标市场策略和产品在地化。

区域动态带来了不同的商业机会和营运考量，这些都应指南市场进入和扩大策略。在美洲，成熟的实验室网络和强大的私人兽医行业推动了对高性能检测设备和检验的检测试剂套件的需求。这种环境有利于那些能够提供强大的技术支援、符合监管要求以及能够同时满足伴侣动物诊疗和大型畜牧业营运需求的综合服务模式的供应商。相较之下，欧洲、中东和非洲地区（EMEA）的管理体制和基础设施能力差异很大。市场参与企业必须满足各种不同的合规要求，同时设计能够适应监管严格市场和实验室能力有限地区的解决方案。战略伙伴关係和区域分销协议通常在企业在这个多元化地区获得市场认可方面发挥着至关重要的作用。

亚太地区的情况十分复杂，既有快速部署，也有基础设施差异。该地区多个国家正在扩大兽医服务和食品安全计划，从而在宠物食品和畜牧业领域催生了对可扩展诊断技术的需求。同时，当地的生产能力和成本敏感度影响采购决策，迫使跨国公司考虑建立生产伙伴关係、授权合约，并开发符合当地性价比预期的产品版本。动物生产系统的变化、水产养殖的集约化以及对饲料和食品安全监管力度的加大，都将进一步影响该地区的产品优先顺序。在所有地区，物流、监管协调工作以及本地技术支援能力仍然是决定成功部署和持续应用的关键因素。

竞争动态产品组合深度、创新速度、策略联盟和附加价值服务模式，这些因素决定了市场定位和成长路径。

兽医免疫诊断领域的竞争格局融合了成熟跨国诊断公司的优势、专业创新企业的敏捷性以及兽医服务供应商的专业化优势。大型公司通常凭藉全面的、经过验证的检测试剂套件、可靠的试剂和仪器产品组合脱颖而出，并投资于品质保证和法规遵从性，以支持临床应用。同时，规模较小、更灵活的公司往往专注于即时检测、新型化合物或独特的物种特异性诊断，并且在检验创新方法和满足特定应用需求方面更加敏捷。

共同研究模式正变得越来越普遍。仪器製造商和试剂供应商之间的商业性伙伴关係打造了捆绑式解决方案，从而减少了实验室和临床采购人员的整合障碍。同样，与当地经销商和服务供应商的联盟可以将技术支援能力扩展到基础设施各异的地区。竞争优势还取决于售后服务、培训以及能够简化结果解读和报告的数位化工具。在技​​术能力参差不齐的市场中，这些附加价值服务往往决定产品的普及程度。最后，在伴侣动物和牲畜市场，易用性和分析性能的可靠性是购买决策的核心，因此，那些设计出符合最终用户工作流程和监管要求的产品的公司将确保更高的市场接受度。

为加强供应链、改善验证途径、扩大商业性覆盖范围并加速技术在不同兽医领域的应用，提出切实可行的策略建议。

在瞬息万变的环境中，产业领导者应采取一系列切实可行的措施来创造价值并降低营运风险。首先，应优先投资于兼顾分析性能和工作流程效率的检测平台和仪器，确保产品能够满足集中式实验室和分散式临床环境的需求。为此，将验证策略与监管要求和最终用户用例相结合，可加速临床应用并整合到诊疗流程中。其次，应透过供应商多元化、区域製造伙伴关係以及完善的品质系统来增强供应链韧性，从而降低贸易中断带来的风险，并维持试剂的稳定供应。

第三，我们将拓展商业模式，融合线下技术支援与线上采购的便利性，同时满足机构买家和小型临床诊所的需求。为改善分销管道，我们将与实验室网路、动物保健服务机构和研究组织建立策略伙伴关係，共同开发应用产品，并在实际环境中检验其临床效用。第四，我们将投资于数位化工具和数据分析，以增强检测结果的解读、促进监控并实现预测性补货。这些数位化能力不仅能够改善临床决策，还能创造持续的价值流，进而加强顾客关係。

最后，我们将采取区域适应性策略，在遵循全球标准的同时兼顾本地化需求，包括根据各地区的法律规范、成本敏感性和基础设施实际情况调整产品。透过协调一致地实施这些措施，产业相关人员可以增强市场韧性，加速先进诊断技术的应用，并更好地支持不同物种和地区的动物健康。

透过透明的多方法调查方法，结合专家的一手研究、实验室检验和系统的二手分析，获得可靠的洞见。

本分析采用透明的多方法调查方法综合证据，旨在确保研究结果的相关性和严谨性。主要研究包括对实验室主任、兽医临床医生、采购专业人员和行业高管进行结构化访谈，以了解实践现状、验证预期和采购驱动因素。这些质性访谈有助于我们解读技术采纳模式以及影响最终使用者选择的实际限制因素。次要研究包括对科学文献、监管指南和产品文件进行系统性回顾，以检验检测特性并了解每项技术的优点和限制。

在条件允许的情况下，我们审查了实验室层面的检验研究和技术性能数据，以支持关于灵敏度、特异性和工作流程整合的论点。我们的供应链评估利用了公开的贸易数据和行业披露信息，以识别关键的采购依赖关係和物流限制。在整个过程中，我们整合了来自多个资讯来源的信息，以减少偏差，并确保我们的结论既反映科学证据，也反映市场实际情况。调查方法的透明度和资讯来源的可追溯性是我们分析的基础，使相关人员能够评估我们的见解在其自身组织环境中的适用性。

对兽医免疫诊断领域未来成功与否，综合诊断创新、营运韧性和商业性可行性如何决定此问题的总结

总体而言，兽医免疫诊断需要将技术创新与务实的营运策略结合的综合应对方案。诊断试剂研发人员不仅要取得卓越的分析结果，还要设计出符合实验室和临床工作流程、满足物种特异性需求并符合当地监管要求的产品。营运韧性，包括供应商多元化和本地化生产方式，对于维持检测的连续性以及在疫情爆发时提供快速回应至关重要。商业性成功取决于能否透过可靠的供应、有效的售后服务以及增强临床效用的数位化工具来提供捆绑式价值。

未来，那些将产品开发与实际应用案例相结合、投资于完善的验证和品质系统并采用适应性分销模式的相关人员，将更有能力支持伴侣动物、生产动物和水产养殖等各个领域的动物健康。透过整合市场的技术、监管和商业性因素，企业可以製定既能产生临床影响又能带来永续商业性回报的策略。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 扩大照护现场免疫诊断设备在畜牧场快速疾病检测的应用
  • 整合多重免疫测量，实现多种动物病原体的同时检测
  • 开发针对新出现的通用感染疾病的免疫诊断检测方法，以加强监测
  • 融合人工智慧演算法的数位免疫诊断平台的兴起，提高了诊断准确性。
  • 侧向流动免疫检测试纸在现场检测动物健康生物标记中的应用
  • 伴侣动物慢性疾病早期检测免疫诊断生物标记的进展
  • 高通量自动化免疫检测系统在商业动物诊断实验室中的出现
  • 扩大畜牧生产中抗菌素抗药性监测的免疫诊断检测解决方案

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：依产品类型分類的动物免疫诊断市场

  • 免疫检测套件
    • 化学冷光免疫检测套件
    • ELISA（酵素结合免疫吸附试验）套件
    • 萤光免疫分析法套件
    • 横向流动化验套件
    • 免疫测量（RIA）套件
  • 装置
    • 自动化免疫检测系统
    • 化学冷光系统
    • 发光计
    • 微孔盘读数仪
  • 试剂
    • 抗原/抗体
    • 缓衝液和溶液

第九章：依技术分類的动物免疫诊断市场

  • 化学冷光免疫检测
  • ELISA法
  • 流式细胞技术
  • 萤光免疫分析
  • 免疫组织化学（IHC）
  • 侧向流动免疫检测
  • 免疫测量（RIA）
  • 西方印渍术

第十章 依动物类型分類的动物免疫诊断市场

  • 水生动物
  • 伴侣动物
    • 狗
    • 猫
  • 家畜
    • 牛
    • 山羊
    • 家禽
    • 猪

第十一章：按分销管道分類的动物免疫诊断市场

  • 离线
  • 在线的

第十二章 动物免疫诊断市场依应用领域划分

  • 自体免疫疾病诊断试剂
  • 癌症诊断剂
  • 食品安全与品质检验
  • 荷尔蒙和代谢失调诊断剂
  • 感染疾病诊断
  • 妊娠和不孕症检查
  • 毒素检测

第十三章：依最终用户分類的动物免疫诊断市场

  • 诊断实验室
  • 製药和生物技术公司
  • 研究所
  • 兽医医院和诊所

第十四章：按地区分類的动物免疫诊断市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：按组别分類的动物免疫诊断市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：各国动物免疫诊断市场概况

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Agrolabo SpA
    • Bio-Rad Laboratories, Inc.
    • BioChek BV
    • Biogal Galed Labs
    • bioMerieux SA
    • Bionote USA Inc.
    • Biopanda Reagents Ltd.
    • EIKEN CHEMICAL CO.,LTD
    • Elanco Animal Health
    • FUJIFILM Holdings Corporation
    • GD Animal Health
    • Heska Corporation
    • IDEXX Laboratories, Inc.
    • INDICAL BIOSCIENCE GmbH
    • Innovative Diagnostics SAS
    • LABOKLIN GMBH & CO. KG
    • Neogen Corporation
    • QIAGEN NV
    • Randox Laboratories Ltd.
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Thermo Fisher Scientific Inc.
    • URIT Medical Electronic Co., Ltd.
    • Virbac Animal Health India Pvt. Ltd
    • VolitionRx Limited
    • Zoetis Inc.
Product Code: MRR-AD517FAA8B82

The Veterinary Immunodiagnostics Market is projected to grow by USD 2.74 billion at a CAGR of 8.43% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.43 billion
Estimated Year [2025] USD 1.54 billion
Forecast Year [2032] USD 2.74 billion
CAGR (%) 8.43%

A comprehensive orientation to how technological innovation, clinical demand, and operational realities are converging to redefine veterinary immunodiagnostics

Veterinary immunodiagnostics stands at an inflection point where scientific advances and evolving clinical needs converge to reshape how diseases in animals are detected, managed, and prevented. Over the past decade, diagnostic platforms have moved from bespoke laboratory workflows toward more integrated, automated, and rapid-response systems that enable timely clinical decision-making across diverse care settings. As a result, veterinary practitioners, diagnostic laboratories, and research organizations increasingly consider immunodiagnostic solutions not merely as reagents and instruments but as components of broader health management ecosystems that include data analytics, point-of-care capabilities, and supply chain considerations.

This dynamic environment places a premium on adaptability. Stakeholders must reconcile the dual imperatives of technological innovation and operational reliability while navigating shifting regulatory frameworks and procurement practices. Therefore, executives need a clear line of sight into the prevailing diagnostic modalities, product form factors, and the end-user requirements that govern adoption. In addition, supply chain resilience, reagent quality, and interoperability with laboratory information systems have become decisive factors in purchasing decisions. Taken together, these forces necessitate a strategic approach that balances scientific rigor, commercial feasibility, and service delivery models to ensure diagnostic solutions meet the growing complexity of veterinary care.

How rapid assay innovation, workflow automation, and evolving distribution models are jointly reshaping the future of veterinary immunodiagnostics

The landscape of veterinary immunodiagnostics is undergoing transformative shifts driven by converging technological, clinical, and commercial trends. Rapid advances in assay chemistries and detection platforms have improved analytical sensitivity and throughput, enabling earlier and more accurate disease detection. At the same time, the rise of automation and integrated instrumentation has reduced hands-on time and variability, which in turn supports scaling diagnostic services from specialized labs to decentralized clinical settings. Consequently, product design is increasingly guided by the need for workflow efficiency, reproducibility, and compatibility with digital reporting systems.

Parallel to technological gains, clinical demand is expanding in scope and complexity. Practitioners across companion and livestock animal care settings require diagnostics that support preventive health, outbreak response, and food safety assurance. This shift places a premium on multiplexing capability and rapid turnaround, which allow veterinarians and producers to make evidence-based interventions. Moreover, regulatory landscapes and quality assurance expectations are maturing, prompting manufacturers to invest in validation, documentation, and post-market surveillance strategies that demonstrate clinical utility and reliability.

Commercial models are also evolving. Distribution channels now blend traditional offline relationships with growing online procurement pathways that emphasize convenience and quicker replenishment cycles. Strategic partnerships between diagnostics firms, pharmaceutical companies, and laboratory networks are intensifying, as firms seek to combine product portfolios with service delivery to capture greater value. Taken together, these transformative shifts underscore the need for integrated strategies that align product innovation with regulatory compliance, clinical applicability, and scalable distribution.

Operational and procurement consequences of United States tariff measures in 2025 and how industry participants are adapting sourcing and pricing strategies

United States tariff policies implemented in 2025 have introduced a recalibrated set of trade considerations that affect procurement, sourcing strategies, and cost structures within the veterinary immunodiagnostics supply chain. Manufacturers and distributors that rely on cross-border supply of instruments, reagents, and assay components have had to reassess vendor contracts, inventory policies, and supplier diversification to preserve continuity of service. As a result, procurement teams have accelerated supplier qualification processes and increased emphasis on multi-source frameworks to mitigate the risk of single points of failure.

In addition, the tariff environment has sharpened attention toward localized production capabilities and regional manufacturing partnerships. Stakeholders have responded by exploring nearshoring and dual-sourcing tactics that reduce exposure to import levies while preserving access to critical raw materials and specialized components. This operational realignment often requires upfront investments in supplier development and quality systems to ensure that alternative sources meet the validation standards required for diagnostic use. Furthermore, distributors and clinical end users have refined inventory management practices to buffer against episodic supply interruptions, with greater reliance on safety stock and predictive replenishment linked to clinical demand signals.

Importantly, the tariff-driven adjustments have also influenced strategic pricing and contracting approaches. Commercial teams are increasingly negotiating longer-term agreements that include clauses for duty mitigation and supply continuity, and manufacturers are exploring value-added service bundles to justify any price adjustments. Collectively, these responses reflect an industry-wide effort to maintain clinical access to essential immunodiagnostic tools while navigating the practical implications of updated trade measures.

Decoding product, technology, species, distribution, application, and end-user segmentation to inform prioritized product development and commercialization strategies

A nuanced understanding of segmentation reveals where product development and commercial efforts should concentrate to meet diverse clinical and operational needs. When the market is viewed through the lens of product type, three primary categories emerge: Immunoassay Kits, Instruments, and Reagents. Immunoassay Kits span chemiluminescent immunoassay kits, ELISA kits, fluorescence immunoassay kits, lateral flow assay kits, and radioimmunoassay kits, each addressing distinct use cases ranging from high-throughput laboratory testing to rapid point-of-care screening. Instruments include automated immunoassay systems, chemiluminescence systems, luminometers, and microplate readers, offering different balances of throughput, automation, and analytical capability. Reagents cover antigens and antibodies as well as buffers and solutions, which are foundational to assay performance and require consistent quality control.

Looking at technology, the market encompasses chemiluminescence immunoassays, ELISA, flow cytometry, fluorescence immunoassays, immunohistochemistry, lateral flow immunoassays, radioimmunoassay, and Western blotting. Each technology presents distinct strengths: some excel in sensitivity and quantitative output, while others offer rapid, equipment-free deployment suitable for field use. These technological distinctions drive decisions around validation pathways, end-user training, and laboratory integration.

Animal type introductions further refine product priorities. Aquatic animals, companion animals, and livestock animals exhibit different epidemiological profiles and testing requirements. Companion animal diagnostics often prioritize canine and feline applications with a focus on individualized care and preventive screening. Conversely, livestock diagnostics must support cattle, goats, poultry, and swine sectors where herd-level surveillance, rapid outbreak detection, and food safety implications shape product expectations.

Distribution channels bifurcate into offline and online pathways, and each route demands distinct service models. Offline channels traditionally emphasize field sales, technical support, and long-term supply relationships, whereas online procurement accelerates reorder cycles and supports standardized purchasing for institutional buyers. Applications span autoimmune disease diagnostics, cancer diagnostics, food safety and quality testing, hormonal and metabolic disorder diagnostics, infectious disease diagnostics, pregnancy and fertility testing, and toxin detection. These use cases dictate assay design, regulatory requirements, and clinical validation endpoints. Finally, end users include diagnostic laboratories, pharmaceutical and biotechnology companies, research institutes, and veterinary clinics and hospitals, each bringing unique operational constraints and procurement criteria that must be addressed through tailored product features and service offerings.

Taken together, segmentation insights highlight the importance of aligned product portfolios, validation strategies, and channel approaches that reflect the varied demands across technologies, animal types, and end-use contexts.

Regional competitiveness and differentiated demand across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape targeted market strategies and product localization

Regional dynamics present differentiated opportunities and operational considerations that should guide market entry and expansion strategies. In the Americas, well-established laboratory networks and a strong private veterinary sector drive demand for high-performance laboratory instruments and validated assay kits. This environment favors suppliers that offer robust technical support, regulatory alignment, and integrated service models that address both companion animal practices and large-scale livestock operations. In contrast, Europe, Middle East & Africa encompasses a wide spectrum of regulatory regimes and infrastructure capabilities. Here, market participants must navigate varied compliance requirements while designing solutions that are adaptable to both highly regulated markets and regions where laboratory capacity may be more limited. Strategic partnerships and regional distribution agreements often play a decisive role in achieving traction across this diverse geography.

Asia-Pacific presents a complex mix of rapid adoption and infrastructure heterogeneity. Several countries in the region have expanded veterinary services and food safety programs, creating demand for scalable diagnostics across both companion and livestock sectors. At the same time, local manufacturing capabilities and cost sensitivities influence procurement decisions, prompting multinational firms to consider manufacturing partnerships, licensing arrangements, and tailored product versions that meet regional price-performance expectations. Shifts in animal production systems, intensification of aquaculture, and heightened regulatory focus on feed and food safety further influence product priorities in this region. Across all geographies, logistics, regulatory harmonization efforts, and local technical support capabilities remain pivotal factors in determining successful deployment and sustained adoption.

Competitive landscape dynamics driven by portfolio depth, innovation velocity, strategic alliances, and value-added service models that determine market positioning and growth pathways

Competitive dynamics in veterinary immunodiagnostics combine the strengths of established multinational diagnostics firms with the agility of specialized innovators and the domain expertise of veterinary service providers. Leading organizations typically differentiate through comprehensive portfolios that pair instruments with validated assay kits and reliable reagent supplies, and they invest in quality assurance and regulatory compliance to support clinical adoption. In parallel, smaller, nimble companies specialize in point-of-care assays, novel chemistries, or unique species-specific diagnostics, often moving more quickly to validate innovative modalities and to serve niche applications.

Collaboration models are increasingly common. Commercial partnerships between instrument manufacturers and reagent suppliers create bundled solutions that reduce integration friction for laboratory and clinical buyers. Likewise, alliances with local distributors or service providers extend technical support capabilities into regions with diverse infrastructure. Competitive positioning also hinges on post-sale service, training, and digital tools that streamline result interpretation and reporting. These value-added services frequently determine adoption in markets where technical capacity varies. Lastly, firms that align product design with end-user workflows and regulatory requirements secure stronger uptake, as ease of use and confidence in analytical performance are central to purchasing decisions across both companion and production animal markets.

Practical strategic recommendations to fortify supply chains, align validation pathways, and expand commercial reach while accelerating technology adoption across diverse veterinary settings

Industry leaders should pursue a set of pragmatic actions to capture value and mitigate operational risk in a rapidly changing environment. First, prioritize investment in assay platforms and instrumentation that balance analytical performance with workflow efficiency, ensuring that products meet the needs of both centralized laboratories and decentralized clinical settings. To that end, aligning validation strategies with regulatory expectations and end-user use cases will accelerate clinical acceptance and integration into care pathways. Second, reinforce supply chain resilience through supplier diversification, regional manufacturing partnerships, and robust quality systems to reduce exposure to trade-related disruptions and to maintain steady reagent availability.

Third, expand commercial models to blend offline technical engagement with online procurement conveniences, thereby catering to institutional buyers and smaller clinical practices simultaneously. Complementary to distribution adaptations, cultivate strategic partnerships with laboratory networks, animal health services, and research organizations to co-develop applications and to validate clinical utility in real-world settings. Fourth, invest in digital tools and data analytics that enhance assay interpretation, facilitate surveillance, and enable predictive replenishment. Such digital capabilities not only improve clinical decision-making but also create recurring value streams that strengthen customer relationships.

Finally, adopt a regionally adaptive strategy that balances global standards with local customization. This includes tailoring product offerings to meet regional regulatory frameworks, cost sensitivities, and infrastructure realities. By implementing these actions in a coordinated manner, industry players can strengthen market resilience, accelerate adoption of advanced diagnostics, and better support animal health outcomes across species and geographies.

Transparent, multi-method research approach combining primary expert engagement, laboratory validation review, and systematic secondary analysis to ensure robust insights

This analysis synthesizes evidence through a transparent, multi-method research approach designed to ensure relevance and rigor. Primary research included structured interviews with laboratory directors, veterinary clinicians, procurement professionals, and industry executives to capture operational realities, validation expectations, and procurement drivers. These qualitative engagements informed the interpretation of technology adoption patterns and the practical constraints that shape end-user choices. Secondary research involved a systematic review of scientific literature, regulatory guidance, and product documentation to validate assay characteristics and to understand methodological strengths and limitations across technologies.

Where feasible, laboratory-level validation studies and technical performance data were reviewed to corroborate claims regarding sensitivity, specificity, and workflow integration. Supply chain assessments drew upon publicly available trade data and industry disclosures to identify key sourcing dependencies and logistical constraints. Throughout the process, findings were triangulated across multiple sources to mitigate bias and to ensure that conclusions reflect both scientific evidence and market realities. Methodological transparency and source traceability undergird the analysis, enabling stakeholders to evaluate the applicability of insights to their specific organizational contexts.

Concluding synthesis of how integrated diagnostic innovation, operational resilience, and commercial execution together determine future success in veterinary immunodiagnostics

In synthesis, veterinary immunodiagnostics requires an integrated response that couples technological innovation with practical operational strategies. Diagnostic developers must design products that not only achieve analytical excellence but also fit into the workflows of laboratories and clinics, accommodate species-specific needs, and meet regional regulatory expectations. Operational resilience, including supplier diversification and targeted regional manufacturing approaches, is essential to preserve continuity of testing and to support rapid response in outbreak scenarios. Commercial success will hinge on the ability to offer bundled value through reliable supply, meaningful post-sale service, and digital tools that enhance clinical utility.

Looking forward, stakeholders that align product development with real-world use cases, invest in robust validation and quality systems, and adopt adaptive distribution models will be best positioned to support animal health outcomes across companion, production, and aquatic sectors. By synthesizing the technological, regulatory, and commercial dimensions of the market, organizations can craft strategies that deliver both clinical impact and sustainable commercial returns.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of point-of-care immunodiagnostic devices for rapid on-farm disease testing in livestock
  • 5.2. Integration of multiplex immunoassays enabling simultaneous detection of multiple veterinary pathogens
  • 5.3. Development of immunodiagnostic assays targeting emerging zoonotic viruses for enhanced surveillance
  • 5.4. Rise of digital immunodiagnostic platforms incorporating AI algorithms for improved diagnostic accuracy
  • 5.5. Implementation of lateral flow immunoassay test strips for field-based detection of animal health biomarkers
  • 5.6. Advancement of immunodiagnostic biomarkers for early detection of chronic diseases in companion animals
  • 5.7. Emergence of high-throughput automated immunoassay systems in commercial veterinary diagnostic laboratories
  • 5.8. Expansion of immunodiagnostic testing solutions for antimicrobial resistance monitoring in livestock production

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Immunodiagnostics Market, by Product Type

  • 8.1. Immunoassay Kits
    • 8.1.1. Chemiluminescent Immunoassay Kits
    • 8.1.2. ELISA (Enzyme-Linked Immunosorbent Assay) Kits
    • 8.1.3. Fluorescence Immunoassay Kits
    • 8.1.4. Lateral Flow Assay Kits
    • 8.1.5. Radioimmunoassay (RIA) Kits
  • 8.2. Instruments
    • 8.2.1. Automated Immunoassay Systems
    • 8.2.2. Chemiluminescence Systems
    • 8.2.3. Luminometers
    • 8.2.4. Microplate Readers
  • 8.3. Reagents
    • 8.3.1. Antigens & Antibodies
    • 8.3.2. Buffers & Solutions

9. Veterinary Immunodiagnostics Market, by Technology

  • 9.1. Chemiluminescence Immunoassays
  • 9.2. ELISA
  • 9.3. Flow Cytometry
  • 9.4. Fluorescence Immunoassays
  • 9.5. Immunohistochemistry (IHC)
  • 9.6. Lateral Flow Immunoassays
  • 9.7. Radioimmunoassay (RIA)
  • 9.8. Western Blotting

10. Veterinary Immunodiagnostics Market, by Animal Type

  • 10.1. Aquatic Animals
  • 10.2. Companion Animals
    • 10.2.1. Canine
    • 10.2.2. Feline
  • 10.3. Livestock Animals
    • 10.3.1. Cattle
    • 10.3.2. Goats
    • 10.3.3. Poultry
    • 10.3.4. Swine

11. Veterinary Immunodiagnostics Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Veterinary Immunodiagnostics Market, by Application

  • 12.1. Autoimmune Disease Diagnostics
  • 12.2. Cancer Diagnostics
  • 12.3. Food Safety & Quality Testing
  • 12.4. Hormonal & Metabolic Disorder Diagnostics
  • 12.5. Infectious Disease Diagnostics
  • 12.6. Pregnancy & Fertility Testing
  • 12.7. Toxin Detection

13. Veterinary Immunodiagnostics Market, by End User

  • 13.1. Diagnostic Laboratories
  • 13.2. Pharmaceutical & Biotechnology Companies
  • 13.3. Research Institutes
  • 13.4. Veterinary Clinics & Hospitals

14. Veterinary Immunodiagnostics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Veterinary Immunodiagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Immunodiagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Agrolabo S.p.A.
    • 17.3.2. Bio-Rad Laboratories, Inc.
    • 17.3.3. BioChek BV
    • 17.3.4. Biogal Galed Labs
    • 17.3.5. bioMerieux SA
    • 17.3.6. Bionote USA Inc.
    • 17.3.7. Biopanda Reagents Ltd.
    • 17.3.8. EIKEN CHEMICAL CO.,LTD
    • 17.3.9. Elanco Animal Health
    • 17.3.10. FUJIFILM Holdings Corporation
    • 17.3.11. GD Animal Health
    • 17.3.12. Heska Corporation
    • 17.3.13. IDEXX Laboratories, Inc.
    • 17.3.14. INDICAL BIOSCIENCE GmbH
    • 17.3.15. Innovative Diagnostics SAS
    • 17.3.16. LABOKLIN GMBH & CO. KG
    • 17.3.17. Neogen Corporation
    • 17.3.18. QIAGEN N.V.
    • 17.3.19. Randox Laboratories Ltd.
    • 17.3.20. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 17.3.21. Thermo Fisher Scientific Inc.
    • 17.3.22. URIT Medical Electronic Co., Ltd.
    • 17.3.23. Virbac Animal Health India Pvt. Ltd
    • 17.3.24. VolitionRx Limited
    • 17.3.25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. VETERINARY IMMUNODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. VETERINARY IMMUNODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VETERINARY IMMUNODIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL VETERINA